TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
HUMA

Humacyte Inc

Healthcare · Biotechnology

0.5657$ -2.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow HUMA
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +24.9% -2.3% -0.4% -6.0% -6.9% -25.9%
– +5.3% +116.1% -39.0% +10.4% -10.1% +58.9%
– +8.4% -1,084.4% – – – –
– -623.0% – – +538.6% -95.3% -7,622.5%
– -96.1% -30.8% +376.4% +117.6% -31.1% -43.8%
– -96.7% +2,967.2% – -103.6% +808.7% -43.8%
– – – – – – –
– – – -99.8% – – –
– – +1,593.8% -106.7% +1,619.6% -92.4% –
– – +12,910.9% -100.5% – +2,433.5% -46.2%
– – +344.7% -138.1% – – -406.7%
– – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?